Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using imaging biomarkers to accelerate drug development and clinical trials.

Drug discovery today - 15 Feb 2005

Pien Homer H, Fischman Alan J, Thrall James H, Sorensen A Gregory

Abstract excerpt

There is increasing evidence that human medical imaging can help answer key questions that arise during the drug development process. Imaging modalities such as magnetic resonance imaging, computed tomography and positron emission tomography can offer significant insights into the bioactivity, pharmacokinetics and dosing of drugs, in addition to supporting registration applications. In this review, examples from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Diagnostic Imaging
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Evaluation, Preclinical

Share to Magnetic Resonance Imaging

Share to Pharmacokinetics

Share to Tomography, Emission-Computed

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 15708744
DOI: 10.1016/S1359-6446(04)03334-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using imaging biomarkers to accelerate drug development and clinical trials.PMID 15708744Read ↗

Noninvasive imaging in drug discovery and development.Semantic proximity Read ↗

[Molecular imaging for drug development].Semantic proximity Read ↗

Molecular Theranostics: A Primer for the Imaging ProfessionalSemantic proximity Read ↗

Incorporating biomarkers into drug labeling.Semantic proximity Read ↗

What's New for Clinical Whole-body MRI (WB-MRI) in the 21st Century.Semantic proximity Read ↗

Nuclear medicine and molecular imaging advances in the 21st centurySemantic proximity Read ↗

Molecular Imaging in Immunotherapy: A Systematic ReviewSemantic proximity Read ↗

In vivo medical imaging for assessing geroprotective interventions in humansSemantic proximity Read ↗

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy. Implications for Radiopharmaceutical Repurposing (Beyond Oncology)Semantic proximity Read ↗

Molecular tracers for the PET and SPECT imaging of diseaseSemantic proximity Read ↗

Identification of Disease States and Response to Therapy in Humans by Utilizing the Biomarker EGFR for Targeted Molecular Imaging.Semantic proximity Read ↗

Assessing Immunotherapy with Functional and Molecular Imaging and Radiomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.